ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Future Combination Strategies for BRAF-Mutant Melanoma

Jeffrey S. Weber, MD, PhD
Published Online:4:25 PM, Thu March 16, 2017

Jeffrey S. Weber, MD, PhD, deputy director of the Laura and Isaac Perlmutter Cancer Center, co-director of the Melanoma Program, and head of Experimental Therapeutics at NYU Langone Medical Center, discusses combination strategies for BRAF-mutant melanoma.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.